This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Lonza Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by James Budge in Cell Selection and Metabolism Modification
Introduction
James Budge is an accomplished inventor based in Visp, Switzerland. He has made significant contributions to the field of biotechnology, particularly in methods related to cell selection and metabolism modification. His innovative approach has the potential to impact various applications in research and medicine.
Latest Patents
James Budge holds a patent for "Methods of cell selection and modifying cell metabolism." This patent describes compositions and methods for identifying, selecting, or culturing cells that comprise a subject nucleic acid sequence of interest. The process involves introducing a nucleic acid that includes a subject nucleic acid and a sequence encoding an enzyme molecule involved in the biosynthesis of an amino acid into a cell. The cell is then cultivated in media that lacks the amino acid, allowing only those cells with the introduced nucleic acid to grow. Additionally, the method may involve using an inhibitor of the enzyme molecule to enhance the selection process.
Career Highlights
James Budge is currently associated with Lonza Inc., a leading global provider of integrated healthcare solutions. His work at Lonza has allowed him to further develop his innovative ideas and contribute to advancements in biotechnology.
Collaborations
James has collaborated with notable colleagues, including Robert Young and Christopher Mark Smales. These collaborations have fostered a productive environment for innovation and research.
Conclusion
James Budge's work in cell selection and metabolism modification exemplifies the impact of innovative thinking in biotechnology. His contributions continue to pave the way for advancements in the field, showcasing the importance of research and collaboration in driving scientific progress.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
